effect overlay
activetrials
Movement Disorders
Movement Disorders
Parkinson's INSIGHTS Study

An Open-label, Randomized 26-Week Study Comparing Levodopa-Carbidopa INteStInal Gel (LCIG) THerapy to Optimized Medical Treatment (OMT) on NonMotor Symptoms (NMS) in Subjects with Advanced Parkinson's Disease
 

HREC: 2015.171
Principal Investigator: Dr Andrew Evans
Coordinator contact:
Funding: Commercial
Movement Disorders
Movement Disorders
Bone Health in Parkinson's

Bone Health in Recently Diagnosed Patients with Parkinson's Disease Compared to Healthy Age & Sex Matched Controls
 

HREC: 2018.134
Principal Investigator: Dr Andrew Evans
Coordinator contact: Sai Yerra
Funding: Non-Commercial
Movement Disorders
Movement Disorders
Biomarkers of Parkinsonian Syndromes

Proteomics analysis of Parkinson's
 

HREC: 2019.160
Principal Investigator: Dr Andrew Evans
Coordinator contact:
Funding: Non-Commercial
Movement Disorders
Movement Disorders
Clinicodiagnostics in laryngeal movement disorders

Clinicodiagnostic features and treatment outcomes in laryngeal movement disorders
 

HREC: 2020.134
Principal Investigator: Dr Andrew Evans
Coordinator contact: Dr Belinda Cruse
Funding: Non-Commercial
Movement Disorders
Movement Disorders
M20 Advanced Parkinson's Disease

An Open-Label Extension of Studies M15-736 and M20-339 to Evaluate the Safety and Tolerability of 24-Hour Daily Exposure of ABBV-951 in Subjects with Advanced Parkinson's Disease
 

HREC: 2020.172
Principal Investigator: Dr Andrew Evans
Coordinator contact:
Funding: Commercial